6 research outputs found
International chemical identifier for reactions (RInChI).
The IUPAC International Chemical Identifier (InChI) provides a method to generate a unique text descriptor of molecular structures. Building on this work, we report a process to generate a unique text descriptor for reactions, RInChI. By carefully selecting the information that is included and by ordering the data carefully, different scientists studying the same reaction should produce the same RInChI. If differences arise, these are most likely the minor layers of the InChI, and so may be readily handled. RInChI provides a concise description of the key data in a chemical reaction, and will help enable the rapid searching and analysis of reaction databases
Recommended from our members
Leveraging heterogeneous data from GHS toxicity annotations, molecular and protein target descriptors and Tox21 assay readouts to predict and rationalise acute toxicity
Despite the increasing knowledge in both the chemical and biological domains the assimilation and exploration of heterogeneous datasets, encoding information about the chemical, bioactivity and phenotypic properties of compounds, remains a challenge due to requirement for overlap between chemicals assayed across the spaces. Here, we have constructed a novel dataset, larger than we have used in prior work, comprising 579 acute oral toxic compounds and 1,427 non-toxic compounds derived from regulatory GHS information, along with their corresponding molecular and protein target descriptors and qHTS in vitro assay readouts from the Tox21 project. We found no clear association between the results of a FAFDrugs4 toxicophore screen and the acute oral toxicity classifications for our compound set; and a screen using a subset of the ToxAlerts toxicophores was also of limited utility, with only slight enrichment toward the toxic set (Odds Ratio of 1.48). We then investigated to what degree toxic and non-toxic compounds could be separated in each of the spaces, to compare their potential contribution to further analyses. Using an LDA projection, we found the largest degree of separation using chemical descriptors (Cohen’s d of 1.95) and the lowest degree of separation between toxicity classes using qHTS descriptors (Cohen’s d of 0.67). To compare the predictivity of the feature spaces for the toxicity endpoint, we next trained Random Forest (RF) acute oral toxicity classifiers on either molecular, protein target and qHTS descriptors. RFs trained on molecular and protein target descriptors were most predictive, with ROC AUC values of 0.80-0.92 and 0.70-0.85, respectively, across three test sets. RFs trained on both chemical and protein target descriptors combined exhibited similar predictive performance to the single-domain models (ROC AUC of 0.80-0.91). Model interpretability was improved by the inclusion of protein target descriptors, which allow the identification of specific targets (e.g. Retinal dehydrogenase) with literature links to toxic modes of action (e.g. oxidative stress). The dataset compiled in this study has been made available for future application.CEFIC Long-range Research Initiative (CEFIC LRI Award 2012 to Andreas Bender
Improving the prediction of organism-level toxicity through integration of chemical, protein target and cytotoxicity qHTS data.
Prediction of compound toxicity is essential because covering the vast chemical space requiring safety assessment using traditional experimentally-based, resource-intensive techniques is impossible. However, such prediction is nontrivial due to the complex causal relationship between compound structure and in vivo harm. Protein target annotations and in vitro experimental outcomes encode relevant bioactivity information complementary to chemicals' structures. This work tests the hypothesis that utilizing three complementary types of data will afford predictive models that outperform traditional models built using fewer data types. A tripartite, heterogeneous descriptor set for 367 compounds was comprised of (a) chemical descriptors, (b) protein target descriptors generated using an algorithm trained on 190 000 ligand-protein interactions from ChEMBL, and (c) descriptors derived from in vitro cell cytotoxicity dose-response data from a panel of human cell lines. 100 random forests classification models for predicting rat LD50 were built using every combination of descriptors. Successive integration of data types improved predictive performance; models built using the full dataset had an average external correct classification rate of 0.82, compared to 0.73-0.80 for models built using two data types and 0.67-0.78 for models built using one. Pairwise comparisons of models trained on the same data showed that including a third data domain on top of chemistry improved average correct classification rate by 1.4-2.4 points, with p-values <0.01. Additionally, the approach enhanced the models' applicability domains and proved useful for generating novel mechanism hypotheses. The use of tripartite heterogeneous bioactivity datasets is a useful technique for improving toxicity prediction. Both protein target descriptors - which have the practical value of being derived in silico - and cytotoxicity descriptors derived from experiment are suitable contributors to such datasets.We thank Alexander Sedykh, Ivan Rusyn and Alexander Tropsha (University of North Carolina – Chapel Hill) for providing the chemical and qHTS data used in this study. We also thank the European Chemical Industry Council Long-range Research Initiative (CEFIC-LRI) for funding (via the LRI Innovative Science Award 2012 to AB). ICC thanks the Pasteur-Paris International PhD Programme for funding. ICC and TM thank Institut Pasteur for funding. AB and DSM thank Unilever and the European Research Commission (Starting Grant ERC-2013-StG 336159 MIXTURE) for funding.This is the final version of the article. It first appeared from Wiley via http://dx.doi.org/10.1039/C5TX00406
Recommended from our members
Supplementary data files to 'Systematic analysis of protein targets associated with adverse events of drugs from clinical trials and post-marketing reports'
These are various supplementary data files that comprise the underlying data and results of our analysis of associations between reports of adverse events of drugs and in vitro bioactivities, while taking into account drug plasma concentrations. This was part of the PhD research by Ines Smit supervised by Andreas Bender and funded by Lhasa Limited, Leeds.
Adverse event reports were extracted from the Food and Drug Administration Adverse Event Reporting System (FAERS) and from the Side Effect Resource (SIDER). In vitro bioactivities were obtained from the ChEMBL database or predicted using the target prediction tool PIDGIN. Drug plasma concentrations were compiled from literature and from the ChEMBL database.
Description of the files:
Data File S 1. Drug-AE relationships based on FAERS.
Data File S 2. Bioactivity data plus predictions used in the analysis.
Data File S 3. All positive target-AE combinations assessed for FAERS using the unbound plasma concentrations.
Data File S 4. All positive target-AE combinations assessed for SIDER using the unbound plasma concentrations.
Data File S 5. All positive target-AE combinations assessed for FAERS using the constant pChEMBL cut-off.
Data File S 6. All positive target-AE combinations assessed for SIDER using the constant pChEMBL cut-off.
Data File S 7. Share of measured versus predicted bioactivities per target for SIDER.
Data File S 8. Share of measured versus predicted bioactivities per target for FAERS.
Data File S 9. Extracted total drug plasma concentrations with references.
Data File S 10. Computed median unbound plasma concentrations used in the analysis.
Data File S 11. Previously reported safety target associations extracted and mapped to MedDRA terms (PT).
Data File S 12. Previously reported safety target associations extracted and mapped to MedDRA terms (HLT)
Systematic Analysis of Protein Targets Associated with Adverse Events of Drugs from Clinical Trials and Postmarketing Reports.
Adverse drug reactions (ADRs) are undesired effects of medicines that can harm patients and are a significant source of attrition in drug development. ADRs are anticipated by routinely screening drugs against secondary pharmacology protein panels. However, there is still a lack of quantitative information on the links between these off-target proteins and the reporting of ADRs in humans. Here, we present a systematic analysis of associations between measured and predicted in vitro bioactivities of drugs and adverse events (AEs) in humans from two sources of data: the Side Effect Resource, derived from clinical trials, and the Food and Drug Administration Adverse Event Reporting System, derived from postmarketing surveillance. The ratio of a drug's therapeutic unbound plasma concentration over the drug's in vitro potency against a given protein was used to select proteins most likely to be relevant to in vivo effects. In examining individual target bioactivities as predictors of AEs, we found a trade-off between the positive predictive value and the fraction of drugs with AEs that can be detected. However, considering sets of multiple targets for the same AE can help identify a greater fraction of AE-associated drugs. Of the 45 targets with statistically significant associations to AEs, 30 are included on existing safety target panels. The remaining 15 targets include 9 carbonic anhydrases, of which CA5B is significantly associated with cholestatic jaundice. We include the full quantitative data on associations between measured and predicted in vitro bioactivities and AEs in humans in this work, which can be used to make a more informed selection of safety profiling targets
International chemical identifier for reactions (RInChI)
The IUPAC International Chemical Identifier (InChI) provides a method to generate a unique text descriptor of molecular structures. Building on this work, we report a process to generate a unique text descriptor for reactions, RInChI. By carefully selecting the information that is included and by ordering the data carefully, different scientists studying the same reaction should produce the same RInChI. If differences arise, these are most likely the minor layers of the InChI, and so may be readily handled. RInChI provides a concise description of the key data in a chemical reaction, and will help enable the rapid searching and analysis of reaction databases